Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
The new politics of AI: Why fast technological change requires bold policy targets
The upcoming AI Action Summit in Paris is an opportunity to show how we can harness artificial intelligence (AI) as a force for societal, economic, and environmental good.The homes that children deserve: Housing policy to support families
As the government seeks to develop a new child poverty strategy, it will need to grapple with housing – the single largest cost faced by families.Powering up public support for electric vehicles
Tackling greenhouse gas emissions will only work if public support for action remains strong. That means ensuring tangible improvements in people’s lives and heading off any brewing backlash.